E Fréneaux

928 total citations
26 papers, 691 citations indexed

About

E Fréneaux is a scholar working on Clinical Biochemistry, Epidemiology and Pharmacology. According to data from OpenAlex, E Fréneaux has authored 26 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Clinical Biochemistry, 9 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in E Fréneaux's work include Metabolism and Genetic Disorders (10 papers), Drug-Induced Hepatotoxicity and Protection (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). E Fréneaux is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Drug-Induced Hepatotoxicity and Protection (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). E Fréneaux collaborates with scholars based in France, United States and Germany. E Fréneaux's co-authors include Dominique Pessayre, Dominique Larrey, Gilles Labbe, Claude Degott, Philippe Lettéron, Alain Berson, Bernard Fromenty, Jean Genève, P Lettéron and G Babany and has published in prestigious journals such as Journal of Clinical Investigation, Hepatology and Gut.

In The Last Decade

E Fréneaux

24 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Fréneaux France 15 279 213 200 148 106 26 691
D Deschamps France 12 209 0.7× 250 1.2× 212 1.1× 151 1.0× 53 0.5× 20 732
L. Giuliani Italy 18 296 1.1× 237 1.1× 44 0.2× 60 0.4× 188 1.8× 44 806
Stephen A. Borowsky United States 9 111 0.4× 292 1.4× 490 2.5× 68 0.5× 41 0.4× 12 1.1k
MA Robin France 6 139 0.5× 180 0.8× 410 2.0× 51 0.3× 57 0.5× 8 661
Bruno Hagenbuch Switzerland 12 145 0.5× 247 1.2× 124 0.6× 61 0.4× 662 6.2× 18 933
Mélanie Verreault Canada 16 239 0.9× 277 1.3× 122 0.6× 23 0.2× 324 3.1× 31 732
Catherine Spire France 12 370 1.3× 341 1.6× 77 0.4× 20 0.1× 193 1.8× 14 850
Thomas Zysset Switzerland 16 203 0.7× 83 0.4× 249 1.2× 34 0.2× 133 1.3× 30 692
Rahul Shah United States 14 309 1.1× 156 0.7× 48 0.2× 56 0.4× 169 1.6× 36 785
Xiaoxin Cai United States 14 388 1.4× 155 0.7× 75 0.4× 46 0.3× 578 5.5× 16 1.0k

Countries citing papers authored by E Fréneaux

Since Specialization
Citations

This map shows the geographic impact of E Fréneaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Fréneaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Fréneaux more than expected).

Fields of papers citing papers by E Fréneaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Fréneaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Fréneaux. The network helps show where E Fréneaux may publish in the future.

Co-authorship network of co-authors of E Fréneaux

This figure shows the co-authorship network connecting the top 25 collaborators of E Fréneaux. A scholar is included among the top collaborators of E Fréneaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Fréneaux. E Fréneaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alberini, Jean‐Louis, et al.. (2001). Technetium‐99m HMPAO‐Labeled Leukocyte Imaging Compared with Endoscopy, Ultrasonography, and Contrast Radiology in Children with Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 32(3). 278–286.
2.
Alberini, Jean‐Louis, et al.. (2001). Technetium-99m HMPAO-Labeled Leukocyte Imaging Compared with Endoscopy, Ultrasonography, and Contrast Radiology in Children with Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 32(3). 278–286. 23 indexed citations
3.
4.
Berson, Alain, E Fréneaux, Dominique Larrey, et al.. (1994). Possible role of HLA in hepatotoxicity. Journal of Hepatology. 20(3). 336–342. 50 indexed citations
5.
6.
Amendt, Brad A., et al.. (1992). Short-Chain Acyl-Coenzyme A Dehydrogenase Activity, Antigen, and Biosynthesis Are Absent in the BALB/cByJ Mouse. Pediatric Research. 31(6). 552–556. 25 indexed citations
7.
8.
Hammel, Pascal, Dominique Larrey, Jacques Bernuau, et al.. (1990). Acute Hepatitis After Tetrahydroaminoacridine Administration for Alzheimerʼs Disease. Journal of Clinical Gastroenterology. 12(3). 329–331. 35 indexed citations
9.
Fréneaux, E, Bernard Fromenty, Alain Berson, et al.. (1990). Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.. Journal of Pharmacology and Experimental Therapeutics. 255(2). 529–535. 73 indexed citations
10.
Lettéron, Philippe, Véronique Descatoire, Marina Tinel, et al.. (1989). Metabolic activation of the antidepressant tianeptine. Biochemical Pharmacology. 38(19). 3241–3246. 14 indexed citations
11.
Babany, G, Marina Tinel, Philippe Lettéron, et al.. (1989). Inhibitory effects of nilutamide, a new androgen receptor antagonist, on mouse and human liver cytochrome P-450. Biochemical Pharmacology. 38(6). 941–947. 7 indexed citations
12.
Fromenty, Bernard, E Fréneaux, Gilles Labbe, et al.. (1989). Tianeptine, a new tricyclic antidepressant metabolized by β-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. Biochemical Pharmacology. 38(21). 3743–3751. 49 indexed citations
13.
Larrey, Dominique, Alain Berson, François Habersetzer, et al.. (1989). Genetic predisposition to drug hepatotoxicity: Role in hepatitis caused by amineptine, a tricyclic antidepressant. Hepatology. 10(2). 168–173. 33 indexed citations
14.
Larrey, Dominique, Marina Tinel, Gilles Amouyal, et al.. (1989). Genetically determined oxidation polymorphism and drug hepatotoxicity. Journal of Hepatology. 8(2). 158–164. 8 indexed citations
15.
Larrey, Dominique, G Babany, Marina Tinel, et al.. (1989). Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.. British Journal of Clinical Pharmacology. 28(3). 297–304. 17 indexed citations
16.
Fréneaux, E, Gilles Labbe, Philippe Lettéron, et al.. (1988). Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic. Hepatology. 8(5). 1056–1062. 110 indexed citations
17.
Fréneaux, E, et al.. (1988). [Hepatitis caused by cyproheptadine (Periactine). A case and review of the literature].. PubMed. 12(6-7). 573–5. 7 indexed citations
18.
Larrey, Dominique, E Fréneaux, Alain Berson, et al.. (1988). Peliosis hepatis induced by 6-thioguanine administration.. Gut. 29(9). 1265–1269. 37 indexed citations
19.
Fréneaux, E, Gilles Labbe, P Lettéron, et al.. (1988). Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.. Journal of Pharmacology and Experimental Therapeutics. 247(2). 745–750. 32 indexed citations
20.
Genève, Jean, Gilles Labbe, Claude Degott, et al.. (1987). Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.. Journal of Pharmacology and Experimental Therapeutics. 242(3). 1133–1137. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Deschamps Breakdown of academic impact, for papers by L. Giuliani Breakdown of academic impact, for papers by Stephen A. Borowsky Breakdown of academic impact, for papers by MA Robin Breakdown of academic impact, for papers by Bruno Hagenbuch Breakdown of academic impact, for papers by Mélanie Verreault Breakdown of academic impact, for papers by Catherine Spire Breakdown of academic impact, for papers by Thomas Zysset Breakdown of academic impact, for papers by Rahul Shah Breakdown of academic impact, for papers by Xiaoxin Cai
Rankless by CCL
2026